Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Stifel Nicolaus Keeps Their Buy Rating on HEALWELL AI (AIDX)

Tipranks - Tipranks - Sat Mar 21, 8:38AM CDT

Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on HEALWELL AI today and set a price target of C$3.10.

Claim 70% Off TipRanks Premium

Keywood covers the Healthcare sector, focusing on stocks such as WELL Health Technologies Corp, HEALWELL AI, and Cipher Pharmaceuticals. According to TipRanks, Keywood has an average return of -4.0% and a 44.91% success rate on recommended stocks.

Currently, the analyst consensus on HEALWELL AI is a Strong Buy with an average price target of C$3.03.

See Insiders’ Hot Stocks on TipRanks >>

Based on HEALWELL AI’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of C$30.35 million and a GAAP net loss of C$27.86 million. In comparison, last year the company earned a revenue of C$13.74 million and had a GAAP net loss of C$10.57 million

Read More on TSE:AIDX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).